COMPOUNDS PROMOTING OCULAR HEALTH

Brand Owner (click to sort) Address Description
EYEPROMISE ZeaVision 716 Crown Industrial Court, Suite I St. Louis MO 63005 COMPOUNDS FOR PROMOTING OCULAR HEALTH AND TREATING EYE DISEASE, NAMELY, PHARMACEUTICALS, DIETARY SUPPLEMENTS, EYE DROPS, EYE WASHES, NUTRACEUTICALS, NUTRITIONAL SUPPLEMENTS, OPHTHALMOLOGIC PREPARATIONS, AND VITAMINS, ALL CONTAINING ZEAXANTHIN, A CAROTENOID;
EZ TEARS ZeaVision 716 Crown Industrial Court, Suite I ST. LOUIS MO 63005 Compounds for promoting ocular health and treating other health issues related to dry eyes and irritation, namely, pharmaceuticals, dietary supplements, eye drops, medicated eye washes, nutraceuticals, nutritional supplements, ophthalmologic preparations, and vitamins;TEARS;
INTERNAL SUNGLASSES ZeaVision 716 Crown Industrial Court, Suite I ST. LOUIS MO 63005 Compounds for promoting ocular health and treating eye disease, namely, [ pharmaceuticals, ] dietary supplements, [ eye drops, eye washes, ]nutraceuticals, nutritional supplements, [ ophthalmologic preparations, ] and vitamins, all containing zeaxanthin, a carotenoid;
MORE OF WHAT YOUR EYES NEED MOST ZeaVision 716 Crown Industrial Court, Suite I ST. LOUIS MO 63005 Compounds for promoting ocular health and treating eye disease, namely, pharmaceuticals, dietary supplements, eye drops, eye washes, nutraceuticals, nutritional supplements, ophthalmologic preparations, and vitamins, all containing zeaxanthin, a carotenoid;
SCREEN SHIELD ZeaVision 716 Crown Industrial Court, Suite I St. Louis MO 63005 Compounds for promoting ocular health and other health issues related to excessive screen time, namely, dietary supplements, food supplements, nutraceuticals, nutritional supplements, and vitamins;SCREEN;
THE OFFICIAL EYE VITAMIN OF ESPORTS ZeaVision 716 Crown Industrial Court, Suite I ST. LOUIS MO 63005 Compounds for promoting ocular health and other health issues related to excessive screen time, namely, pharmaceuticals, dietary supplements, food supplements, eye drops, oral strips, inhalables, dietary supplemental drinks, nutraceuticals, nutritional supplements, ophthalmologic preparations, and vitamins;
THE OFFICIAL EYE VITAMIN OF SPORTS ZeaVision 716 Crown Industrial Court, Suite I ST. LOUIS MO 63005 Compounds for promoting ocular health and other health issues related to excessive screen time, namely, dietary supplements, food supplements, nutraceuticals for use as a dietary supplement, nutritional supplements, and vitamins;EYE VITAMIN;
UPGRADE YOUR EYES ZeaVision 716 Crown Industrial Court, Suite I St. Louis MO 63005 Compounds for promoting ocular health and other health issues related to excessive screen time, namely, pharmaceuticals, dietary supplements, food supplements, eye drops, oral strips, inhalables, dietary supplemental drinks, nutraceuticals, nutritional supplements, ophthalmologic preparations, and vitamins;
VITAMIN Z ZeaVision 716 Crown Industrial Court, Suite I St. Louis MO 63005 compounds for promoting ocular health and treating eye disease, namely pharmaceuticals, dietary supplements, eye drops, eyewashes, nutraceuticals, nutritional supplements, ophthalmologic preparations, and vitamins, all containing zeaxanthin, a carotenoid;VITAMIN ZED;
VIZUAL EDGE ZeaVision 716 Crown Industrial Court, Suite I ST. LOUIS MO 63005 Compounds for promoting ocular health and treating eye disease, namely pharmaceuticals, dietary supplements, eye drops, eye washes, nutraceuticals, nutritional supplements, ophthalmologic preparations, and vitamins, all containing the carotenoid zeaxanthin;VISUAL EDGE;VISUAL;
VIZUAL EDGE ZeaVision 716 Crown Industrial Court, Suite I ST. LOUIS MO 63005 Compounds for promoting ocular health and treating eye disease, namely, dietary supplements, nutraceuticals, nutritional supplements, and vitamins, all containing the carotenoid zeaxanthin;VISUAL;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The subject invention provides a mechanism by which steroidal quinol compounds confer beneficial ophthalmic effects. The subject compounds possess a lipophilic-hydrophilic balance for transcorneal penetration and are readily reduced into parent phenolic A-ring steroid compounds to provide protection or treatment against various ocular symptoms and disorders. The compounds according to the subject invention appear to be highly advantageous as prodrugs to provide protection and/or treatment against ocular disorders. These prodrugs confer lipid solubility optimal for transocorneal penetration and are readily converted to endogenous reducing agents into active phenolic A-ring steroid compounds. To the extent that these prodrugs have reduced feminizing effects and systemic toxicity, they would be expected to be quite advantageous for protecting or treating the eye against ocular disorders such as cataract or glaucoma without undesired (systemic) side effects).